The potential inhibiton against enzymes target type 2 diabetes’s pathways of leonuriside via virtual studies

This study aims to further characterize LN as a potential inhibitor of α-glucosidase and α-amylase and its high possibility of being developed as an antidiabetic drug via in silico studies.